Respiratory Virus-induced Dysregulation of T-regulatory Cells Leads to Chronic Rejection
Overview
Pulmonary Medicine
Authors
Affiliations
Background: Lower respiratory viral infections predispose to bronchiolitis obliterans syndrome (BOS). In addition, there is emerging evidence to support the role of autoimmunity in the pathogenesis of BOS. Because CD4(+)CD25(+)Foxp3(+) regulatory T-cells (Treg) control autoimmunity, we tested the hypothesis that respiratory virus-induced Treg dysfunction leads to BOS.
Methods: Treg frequency was monitored using flow cytometry. Apoptosis, cytokines, and antibodies were analyzed using annexin V assay, LUMINEX, and enzyme-linked immunosorbent assay, respectively. Murine studies were performed using the orthotopic tracheal transplant model.
Results: (A) Human studies: Treg troughs (decrease >50% of baseline) were found in 13 (43.3%) of 30 lung transplant recipients. Treg isolated during troughs revealed increased apoptosis (37.8%). Patients with Treg troughs had increased prevalence of antibodies to self-antigens collagen type I (23.1% vs 5.8% pretrough), collagen V (7.7% vs 0%), and k-alpha tubulin (30.7% vs 11.7%, p < 0.01) at 6 months post-trough. Increased number of Treg troughs correlated with more rapid onset of BOS. (B) Murine studies: Infection of tracheal transplant recipients with murine parainfleunza sendai virus led to increased Treg apoptosis (50.5%) in the draining lymph nodes. Vaccination against sendai virus prior to transplant abrogated apoptosis of Treg. In vitro, sendai virus-infected, but not naive, tracheal epithelial cells demonstrated upregulation of FasL (>3.5-fold) and induction of co-cultured Treg apoptosis (5.6-fold increase).
Conclusions: Respiratory viral infections cause Treg apoptosis which leads to the development of de novo autoimmunity that may play a role in the pathogenesis of BOS.
Yang W, Lecuona E, Wu Q, Liu X, Sun H, Alam H Front Transplant. 2024; 2:1237671.
PMID: 38993924 PMC: 11235341. DOI: 10.3389/frtra.2023.1237671.
Lymphocytic Airway Inflammation in Lung Allografts.
Santos J, Calabrese D, Greenland J Front Immunol. 2022; 13:908693.
PMID: 35911676 PMC: 9335886. DOI: 10.3389/fimmu.2022.908693.
Ravichandran R, Bansal S, Rahman M, Sureshbabu A, Sankpal N, Fleming T Front Immunol. 2022; 13:861583.
PMID: 35572510 PMC: 9094427. DOI: 10.3389/fimmu.2022.861583.
Apostolopoulou A, Clancy C, Skeel A, Nguyen M Open Forum Infect Dis. 2021; 8(11):ofab478.
PMID: 34805426 PMC: 8600160. DOI: 10.1093/ofid/ofab478.
Immune Responses to SARS-CoV-2 in Solid Organ Transplant Recipients.
Phadke V, Scanlon N, Jordan S, Rouphael N Curr Transplant Rep. 2021; 8(2):127-139.
PMID: 33688459 PMC: 7931983. DOI: 10.1007/s40472-021-00322-5.